ES2095017T3 - Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete. - Google Patents

Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete.

Info

Publication number
ES2095017T3
ES2095017T3 ES93402134T ES93402134T ES2095017T3 ES 2095017 T3 ES2095017 T3 ES 2095017T3 ES 93402134 T ES93402134 T ES 93402134T ES 93402134 T ES93402134 T ES 93402134T ES 2095017 T3 ES2095017 T3 ES 2095017T3
Authority
ES
Spain
Prior art keywords
singulet
cosmetic
association
peroxidase
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93402134T
Other languages
English (en)
Inventor
Guyen Quang Lan N
Christian Colin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2095017T3 publication Critical patent/ES2095017T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA ASOCIACION DE UNA PEROXIDASA CAPAZ DE REDUCIR LOS PEROXIDOS ORGANICOS Y DE UN ANTIOXIDANTE CAPAZ DE NEUTRALIZAR EL OXIGENO "SINGULET", PERMITE PREVENIR O TRATAR DEFICIENCIAS CELULARES PROVOCADAS POR LOS RADICALES LIBRES INDUCIDOS POR LOS CONTAMINANTES ATMOSFERICOS O MEDIANTE LA RADIACION ULTRAVIOLETA. SE OBTIENEN DE ESTA FORMA COMPOSICIONES COSMETICAS O DERMOFARMACEUTICAS QUE PERMITEN COMBATIR EL ENVEJECIMIENTO ACELERADO DE LA PIEL, Y REDUCIR LOS PELIGROS DE CANCER CUTANEO FOTOINDUCIDO.
ES93402134T 1992-09-01 1993-09-01 Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete. Expired - Lifetime ES2095017T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9210439A FR2695034B1 (fr) 1992-09-01 1992-09-01 Composition cosmétique ou pharmaceutique comprenant en association une peroxydase et un agent anti-oxygène singulet.

Publications (1)

Publication Number Publication Date
ES2095017T3 true ES2095017T3 (es) 1997-02-01

Family

ID=9433115

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93402134T Expired - Lifetime ES2095017T3 (es) 1992-09-01 1993-09-01 Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete.

Country Status (9)

Country Link
US (1) US6316012B1 (es)
EP (1) EP0586303B1 (es)
JP (1) JP2731705B2 (es)
AT (1) ATE143589T1 (es)
AU (1) AU671134B2 (es)
CA (1) CA2105230C (es)
DE (1) DE69305135T2 (es)
ES (1) ES2095017T3 (es)
FR (1) FR2695034B1 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737115B1 (fr) * 1995-07-25 1997-08-22 Oreal Composition stable contenant une enzyme
JP2993425B2 (ja) * 1995-12-20 1999-12-20 株式会社村田製作所 積層セラミックコンデンサ
DE19739044A1 (de) * 1997-09-05 1999-03-11 Beiersdorf Ag Verwendung von Dihydrorobinetin als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen
DE19739349A1 (de) * 1997-09-09 1999-03-11 Beiersdorf Ag Verwendung von Troxerutin als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen
DE19742025A1 (de) * 1997-09-24 1999-03-25 Beiersdorf Ag Verwendung von Flavonen und Flavonoiden zur Hautaufhellung oder zur Verhinderung der durch oxidative Proteinaggregation hervorgerufenen Altersflecken
FR2781156B1 (fr) * 1998-07-20 2001-06-29 Lafon Labor Composition pharmaceutique destinee notamment a la prevention et au traitement des radiomucites et des chimiomucites
WO2000024365A1 (en) 1998-10-26 2000-05-04 University Of Massachusetts Treatment of skin with adenosine or adenosine analog
JP2000319159A (ja) * 1999-05-10 2000-11-21 Nonogawa Shoji Kk 皮膚外用剤
DE10003786A1 (de) * 2000-01-28 2001-08-02 Merck Patent Gmbh Galenische Formulierung
FR2808192A1 (fr) * 2000-04-28 2001-11-02 Oreal Epichatechine comme inhibiteur de no-synthase et utilisations
DE10036655A1 (de) * 2000-07-26 2002-02-07 Basf Ag Kosmetische oder dermatologische Zubereitungen zur Vermeidung von Hautschädigungen durch Peroxide
DE10054341A1 (de) * 2000-11-02 2002-05-08 Beiersdorf Ag Verwendung von einem oder mehreren Wirkstoffen, gewählt aus der Gruppe der Flavone, Flavanone und Flavanoide zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
WO2002044313A1 (en) * 2000-12-01 2002-06-06 Novozymes A/S Encapsulation of compounds in vesicles
JP4300034B2 (ja) * 2001-05-29 2009-07-22 イーエルシー マネージメント エルエルシー ローズマリー抽出物およびｄｈａを含有する化粧品組成物
WO2003013556A1 (en) * 2001-08-02 2003-02-20 Chiduko Yamagami Medicinal compositions having effects of ameliorating eye diseases and holding eye functions
ITMI20020189A1 (it) * 2002-02-01 2003-08-01 Giuliani Spa Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
US7314634B2 (en) * 2002-02-22 2008-01-01 Steven Hernandez Use of polyphenols to treat skin conditions
US20030224077A1 (en) * 2002-04-08 2003-12-04 Societe L'oreal S.A. Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
CA2487789C (en) * 2002-05-20 2012-04-03 Otsuka Pharmaceutical Co., Ltd. Composition for improving melasma and composition for reducing skin dullness
DE10226700A1 (de) * 2002-06-15 2004-01-08 Cognis Deutschland Gmbh & Co. Kg Verwendung von Astaxathin
TR200301291A2 (tr) * 2002-08-20 2004-02-23 Dart Industries Inc. Şekil verilmiş gıda maddelerinin oluşturulması için ayarlanabilir kalıp
US7534453B1 (en) 2002-09-05 2009-05-19 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticles and use in enhancing cell survivability
JP4492786B2 (ja) * 2004-02-16 2010-06-30 三菱瓦斯化学株式会社 感放射線性組成物
CN1993060A (zh) 2004-08-19 2007-07-04 帝斯曼知识产权资产管理有限公司 可脂溶物质的新型组合物
GB0501365D0 (en) * 2005-01-21 2005-03-02 Promar As Compositions
US8084268B2 (en) * 2005-02-25 2011-12-27 L'oreal Method of evaluating the potential of the skin for scavenging free radicals
FR2882595B1 (fr) * 2005-02-25 2007-05-25 Oreal Procede pour evaluer le potentiel de desactivation de radicaux libres de la peau
US8703200B2 (en) * 2005-04-29 2014-04-22 The Board Of Regents Of The University Of Oklahoma Inhibition of neovascularization by cerium oxide nanoparticles
DE102006017879A1 (de) * 2006-04-13 2007-10-25 Merck Patent Gmbh Verwendung von Flavonoiden
US7959949B2 (en) 2006-04-27 2011-06-14 University Of Central Florida Research Foundation, Inc. Functionalized nanoceria composition for ophthalmic treatment
FR2902326B1 (fr) 2006-06-20 2008-12-05 Oreal Utilisation de la coumarine, de butylated hydroxyanisole et d'ethoxyquine pour le traitement de la canitie
KR101644763B1 (ko) * 2007-05-17 2016-08-01 엔테그리스, 아이엔씨. Ｃｍｐ후 세정 제제용 신규한 항산화제
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
US8916199B1 (en) 2008-04-25 2014-12-23 University of Central Florida Research Foundation, Ind. Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
US9127202B1 (en) 2008-07-18 2015-09-08 University Of Central Florida Research Foundation, Inc. Biocompatible nano rare earth oxide upconverters for imaging and therapeutics
US8883519B1 (en) 2009-03-17 2014-11-11 University Of Central Florida Research Foundation, Inc. Oxidase activity of polymeric coated cerium oxide nanoparticles
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
US8795731B1 (en) 2009-10-12 2014-08-05 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation
TWI492744B (zh) * 2009-12-04 2015-07-21 Abbott Lab 使用類胡蘿蔔素調節早產兒發炎症之方法
JP5770428B2 (ja) * 2010-03-09 2015-08-26 株式会社コーセー 一重項酸素消去剤、並びに該一重項酸素消去剤を用いた皮膚外用剤及び化粧料
US20130129651A1 (en) * 2010-08-03 2013-05-23 Hayashibara Co., Ltd. Agent for enhancing the effect of skin-whitening ingredients and uses thereof
WO2012036786A1 (en) 2010-09-17 2012-03-22 University Of L'aquila Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
US8951539B1 (en) 2011-06-07 2015-02-10 University Of Central Florida Research Foundation, Inc. Methods of promoting angiogenesis using cerium oxide nanoparticles
US9161950B2 (en) 2011-09-21 2015-10-20 University Of Central Florida Foundation, Inc. Neuronal protection by cerium oxide nanoparticles
WO2014095318A2 (en) * 2012-12-21 2014-06-26 Unilever Plc Method of preventing hair fibre damage
US9463437B2 (en) 2013-02-14 2016-10-11 University Of Central Florida Research Foundation, Inc. Methods for scavenging nitric oxide using cerium oxide nanoparticles
JP7778470B2 (ja) * 2019-06-06 2025-12-02 花王株式会社 大気有害物質の付着抑制方法
JP7761374B2 (ja) * 2019-06-06 2025-10-28 花王株式会社 大気有害物質の付着抑制方法
JP7752472B2 (ja) * 2019-06-06 2025-10-10 花王株式会社 大気有害物質の付着抑制方法
JP2020200315A (ja) * 2019-06-06 2020-12-17 花王株式会社 大気有害物質の付着抑制方法
JP7671571B2 (ja) * 2019-06-06 2025-05-02 花王株式会社 大気有害物質の付着抑制方法
KR102692144B1 (ko) * 2019-06-06 2024-08-05 카오카부시키가이샤 대기 유해 물질의 부착 억제 방법
US20250313777A1 (en) * 2024-03-21 2025-10-09 The Procter & Gamble Company Treatment compositions comprising ethoxyquin

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1013014B (it) * 1970-11-09 1977-03-30 Procter & Gamble Soluzione per tingere capelli e composizione in esso impiegata
US3957424A (en) * 1971-10-27 1976-05-18 The Procter & Gamble Company Enzyme-activated oxidative process for coloring hair
LU71110A1 (es) 1974-10-15 1976-11-11
FR2315991A1 (fr) 1975-06-30 1977-01-28 Oreal Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes
IL51342A (en) 1977-01-27 1980-11-30 Abic Ltd Ethoxyquin derivatives,their preparation and pharmaceutical and veterinary compositions comprising them
LU77995A1 (fr) 1977-08-19 1979-05-23 Oreal Compositions tinctoriales a base de colorants directs contenant un acide(2,5-dihydroxyphenyl)carboxylique ou l'un de ses sels et procede de preparation
LU77994A1 (fr) 1977-08-19 1979-05-23 Oreal Compositions tinctoriales a base de colorants d'oxydation comprenant un acide(2,5-dihydroxyphenyl)alcanoique ou l'un de ses sels a titre d'anti-oxydant et procede de preparation
FR2416008A1 (fr) 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
JPS55111411A (en) 1979-02-19 1980-08-28 Sansho Seiyaku Kk Cosmetic for making fair skin
US4473550A (en) * 1981-01-16 1984-09-25 Rosenbaum Robert S Bactericidal compositions and methods
US4609544A (en) 1983-07-05 1986-09-02 Repligen Corporation Process for tanning the skin
FR2600250B1 (fr) 1986-06-23 1989-11-24 Bio Serae Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee
DK501686A (da) * 1986-10-20 1988-04-21 Otto Melchior Poulsen Enzymholdigt, baktericidt middel samt tandplejemidler og saarbehandlingsmidler, som indeholder det
FR2610626B1 (fr) 1987-02-09 1989-05-19 Oreal Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant
FR2620024B1 (fr) 1987-09-09 1991-03-15 Dermatologiques Et Composition cosmetique comportant un agent antiradicaux libres, et agent correspondant
CH672048A5 (es) 1987-09-16 1989-10-31 Nestle Sa
DD268157A1 (de) * 1988-01-13 1989-05-24 Berlin Kosmetik Veb Dermopharmazeutisches praeparat
US4956184A (en) 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
FR2646777B1 (fr) 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
CA2067334C (en) 1989-11-03 2001-02-13 Jeffrey J. Seilhamer Recombinant production of lactoperoxidase
LU87672A1 (fr) 1990-02-05 1991-10-08 Oreal Procede de preparation d'un pigment melanique par voie enzymatique
JP2844103B2 (ja) 1990-02-09 1999-01-06 株式会社コーセー 皮膚外用剤
GB9015910D0 (en) * 1990-07-19 1990-09-05 Univ Bruxelles Novel use
CA2073353C (fr) 1990-11-14 2003-10-28 Alexandre Zysman Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes
FR2670384A1 (fr) 1990-12-12 1992-06-19 Oreal Composition cosmetique liquide nettoyante a deux phases, contenant au moins un dialkylphtalate.
JP3103167B2 (ja) * 1991-10-30 2000-10-23 雪印乳業株式会社 老化防止剤
FR2699818B1 (fr) * 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.

Also Published As

Publication number Publication date
CA2105230C (fr) 2005-03-08
ATE143589T1 (de) 1996-10-15
FR2695034A1 (fr) 1994-03-04
EP0586303A1 (fr) 1994-03-09
JPH06227961A (ja) 1994-08-16
AU4485093A (en) 1994-03-10
CA2105230A1 (fr) 1994-03-02
AU671134B2 (en) 1996-08-15
EP0586303B1 (fr) 1996-10-02
DE69305135T2 (de) 1997-04-03
US6316012B1 (en) 2001-11-13
JP2731705B2 (ja) 1998-03-25
FR2695034B1 (fr) 1994-10-07
DE69305135D1 (de) 1996-11-07

Similar Documents

Publication Publication Date Title
ES2095017T3 (es) Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete.
ES2090631T3 (es) Utilizacion de esfingolipidos, en la preparacion de una composicion cosmetica o dermofarmaceutica que protege la piel y los cabellos contra los efectos nocivos de la polucion atmosferica.
ES2176795T3 (es) Composiciones a base de esfingomielanasa y su utilizacion.
MXPA01006917A (es) Composicion topica que comprende n-acetilaldosaminas o acidos n-acetilaminos.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
MX9702415A (es) Extractos de cocoa antineoplastica y metodos para elaborar y usar los mismos.
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
AR004089A1 (es) Utilizacion de un antagonista de substancia p en una composicion topica , como agente antitranspirante.
AR013265A1 (es) Reduccion del crecimiento del pelo.
ES2094033T3 (es) Composicion cosmetica y/o dermatologica que contiene derivados de acido salicilico y procedimiento de solubilizacion de estos derivados.
ES2152710T3 (es) Preparados cosmeticos para aplicacion topica que contienen extractos de phyllanthus emblica y centella asiatica y/o bacopa monnieri.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
ES2182837T3 (es) Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus.
ES2137372T3 (es) Solucion antifungica para las uñas.
ES2159560T3 (es) Inhibicion del crecimiento del pelo.
ES2109066T3 (es) Composiciones cosmeticas autobronceadoras a base de dihidroxiacetona, de alquilpoliosidos y de alcohol graso.
MX9703648A (es) Metodos y composiciones para el acondicionamiento de la piel y el cabello.
ES2121779T3 (es) Utilizacion de espiperona como agente inmunosupresor y antiinflamatorio.
ES2137044T3 (es) Utilizacion de derivados de oxazolidinona como agentes antipenetrantes en una composicion cosmetica y/o dermatologica.
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
ES2065647T3 (es) Empleo cosmetico de una composicion que tiene una actividad antieritematosa.
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ES2089154T3 (es) Composicion cosmetica.
ES2102284T5 (es) Composicion cosmetica que comprende una asociacion de ceramidas y su utilizacion.
ES2172095T3 (es) Utilizacion de sulfitos y metabisulfitos, para la fabricacion de composiciones cosmeticas o farmaceuticas, particularmente en dermatologia, con efecto inhibidor de la melanogenesis o con actividad despigmentante.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 586303

Country of ref document: ES